Cas Medical Systems Inc 2018 Q3 Institutional Investor Sentiment Better Than Expected

CAS Medical Systems, Inc. (NASDAQ:CASM) Logo

Sentiment for Cas Medical Systems Inc (NASDAQ:CASM)

Cas Medical Systems Inc (NASDAQ:CASM) institutional sentiment increased to 3.75 in Q3 2018. Its up 2.08, from 1.67 in 2018Q2. The ratio has increased, as 15 investment managers started new or increased stock positions, while 4 trimmed and sold positions in Cas Medical Systems Inc. The investment managers in our partner’s database reported: 16.08 million shares, up from 6.98 million shares in 2018Q2. Also, the number of investment managers holding Cas Medical Systems Inc in their top 10 stock positions increased from 0 to 1 for an increase of 1. Sold All: 2 Reduced: 2 Increased: 9 New Position: 6.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $54.34 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

The stock decreased 4.88% or $0.1 during the last trading session, reaching $1.95. About 87,181 shares traded or 113.51% up from the average. CAS Medical Systems, Inc. (NASDAQ:CASM) has risen 204.76% since January 14, 2018 and is uptrending. It has outperformed by 204.76% the S&P500.

Analysts await CAS Medical Systems, Inc. (NASDAQ:CASM) to report earnings on March, 13. They expect $-0.07 earnings per share, 0.00 % or $0.00 from last year’s $-0.07 per share. After $-0.06 actual earnings per share reported by CAS Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 16.67 % negative EPS growth.

Acuta Capital Partners Llc holds 4.28% of its portfolio in CAS Medical Systems, Inc. for 5.26 million shares. Eam Investors Llc owns 401,435 shares or 0.14% of their US portfolio. Moreover, Ingalls & Snyder Llc has 0.05% invested in the company for 501,063 shares. The New York-based Penbrook Management Llc has invested 0.05% in the stock. Family Management Corp, a New York-based fund reported 19,794 shares.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Positions Chart

(adsbygoogle = window.adsbygoogle || []).push({});

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.